[1] [2] The most commonly reported side effects in clinical trials were gastrointestinal, including nausea (occurring in 12-29% of patients), diarrhea, vomiting, constipation, and abdominal discomfort
A.GribbleF
John Winhusen, University of Cincinnati Semaglutide for Helping Opioid Recovery (SHORE) Status: Development Brigham and Womens 12week pilot, doubleblind, placebocontrolled, randomized trial to evaluate semaglutide in individuals with opioid use disorder who are newly initiating buprenorphine
UnitedHealth Group/OptumRx monetizes claims data as a secondary IP stream, selling analytical products back to the same manufacturers whose formulary positioning it controls
Chronic pain often involves nervous system sensitization, metabolic dysfunction, nutrient depletion, or low-grade inflammation that may not appear on standard imaging or routine laboratory tests
: BPC 157